Events
Search Results
Speaking Engagements
5.08.26
Stanford Biotech Group: Innovations in Biotechnology Symposium 2026
Wilson Sonsini is pleased to partner with the Stanford Biotechnology Group for a full-day symposium bringing together leaders across biotech, pharma, venture capital, and academia to explore cutting-edge innovations shaping the future of medicine. Julia Minitti's session will be a moderated panel from 5:00-5:45 PM. The session is titled "Protecting Your Research with IP" and will also include an IP associate from Stanford's OTL.
Speaking Engagements
2.12.26
The IP ABCs of ADCs
Join Wilson Sonsini for a Drug Hunter Flash Talk webinar featuring Deborah Smith and Julia Minitti, partners in the Patents and Innovations group, as they explore how antibody-drug conjugates (ADCs) are reshaping the oncology landscape and what that means for intellectual property strategy. Drawing on Drug Hunter’s mission to deliver actionable insights for drug discovery professionals, this session will provide a practical roadmap for building durable IP portfolios in an increasingly crowded ADC space. The discussion will cover best practices for layering patent protection across ADC components, managing freedom-to-operate risk early in R&D, and navigating recent USPTO developments that can directly impact the long-term commercial success of ADC programs.
Affiliated Programs
12.02.25
PBSS: Use of Enabling Formulation Technologies To Enhance Bioavailability and Manufacturability for Oral Small Molecule Drug Product Development: From Lead Optimization and Candidate Nomination Through Clinical Development
Wilson Sonsini is pleased to be a 2025 sponsor of the Pharmaceutical and Biomedical Sciences Society International (PBSS).
Affiliated Programs
3.11.25
PBSS Webcast: Artificial Intelligence and Machine Learning to Drive Therapeutic Drug Discovery & Development
Wilson Sonsini is pleased to sponsor the two-day PBSS webcast from Boston entitled Artificial Intelligence and Machine Learning to Drive Therapeutic Drug Discovery & Development. Artificial intelligence (AI) and machine learning (ML) are powerful buzzwords in biotech. Learn how companies use AI/ML to increase efficiency in drug discovery and development and how AI/ML can increase the probability of clinical success. On Day 1, partner Julia Minitti will present IP Considerations for AI in Drug Discovery.
Affiliated Programs
2.06.25
PBSS Workshop: Intellectual Property Strategies and Best Practices
Wilson Sonsini is proud to partner with the Pharmaceutical & BioScience Society (PBSS) to present a workshop on intellectual property strategies and best practices on Thursday, February 6 at the Crowne Plaza Foster City.
Affiliated Programs
1.14.25
Next in TechBio | Computational Drug Discovery and Data-driven Innovation
Wilson Sonsini is pleased to sponsor the Integrated Biosciences Next in TechBio event. Join us for a special cocktail evening to explore computational drug discovery and the transformative power of data-driven innovations. Featuring Eli Lilly’s Chief AI Officer moderating a panel discussion with TechBio CEOs from Integrated Biosciences, BigHat Biosciences, Owkin, Atommap, and Qubit Pharmaceuticals. There is also a Fireside Chat moderated by Benchling's CEO and participation with Wilson Sonsini Bay Area firm partners.
Speaking Engagements
12.10.24
PBSS Workshop: Intellectual Property of ADCs
On Tuesday, December 10th, partner Julia Minitti will be speaking on the panel, Intellectual Property of ADCs as part of the PBSS workshop, "Antibody-Drug Conjugates from Discovery to Development: Chemistry, Engineering, Characterization, CMC, PK/Tox, Clinical Design and Intellectual Property."
Speaking Engagements
3.28.24
Antibody-Drug Conjugates from Discovery to Development: Chemistry, Engineering, Characterization, CMC, PK/Tox, Clinical design and Intellectual Property
Wilson Sonsini partners Julia Minitti and Maya Skubatch recently spoke at the Antibody-Drug Conjugates Workshop hosted by Pharmaceutical & BioScience Society International. The workshop brought together various professionals and scientists to discuss the chemistry and engineering of antibody-drug conjugates (ADCs), clinical trials, intellectual property and more. Pharmaceutical & BioScience Society, International (PBSS) is a non-profit professional organization of scientists and other professionals in the life science sector, working in diverse organizations such as the biotechnology and pharmaceutical industries, instrumentation and scientific product suppliers, academia, government laboratories and contract research organizations. Many thanks to PBSS President Shichang Miao and the organizers for a fantastic opportunity to present!
Affiliated Programs
5.23.23
NextGen VC Forum: Expanding Skills and Expertise Co-hosted with LaunchBio
Curated by Wilson Sonsini's Michael Hostetler and Dan Koeppen, LaunchBio’s NextGen VC Forum is the premiere event for venture capital associates to expand their skills and expertise while growing their network. The half-day forum includes a networking breakfast, three one-hour sessions and lunch. Attendance at NextGen VC Forum is by invitation only; if interested, please contact your firm’s senior partners.
WSGR Events
3.25.21
Innovator’s Edge Series: Regulatory Strategies in the Life Sciences
Wilson Sonsini is pleased to present the first of our 2021 Innovator’s Edge Series. Start-ups in the life sciences and biotech sectors, with an urgency to see their products come to market, continue to react to today’s ever-changing business and regulatory landscape. With an abundance of life sciences companies in the spotlight, regulatory strategic planning is more urgent than ever. The stakes are high as companies are faced with the task of navigating regulatory requirements and coordinating regulatory activity with business and patent strategies.